New study quantifies the impact of COVID-19, with 56% of executives moving marketing spend to online events and digital media and 39% planning to scale-back staffing. Cannabis executives report slashing budgets and significant disruption to suppliers and services during the COVID-19 crisis, according to a new report published by Cannabis Business Executive (CBE) and cannabis […]
Coronavirus
High stakes: How cannabis retailers can operate safely during and in the aftermath of coronavirus (COVID-19)
By Alison B. Torbitt, Staci Jennifer Riordan, Hillary Baca, Rachel L. Conn Cannabis companies, deemed essential businesses in many states, continue operating despite the COVID-19 pandemic. While many cannabis companies are struggling to stay open without eligibility for the Small Business Administration loans authorized by Congress, remaining operational has other considerations regarding how to revamp […]
Curating Consumer Insights for the Cannabis Industry
Amid the COVID-19 pandemic and the rising wave of mass demonstrations sparked by the tragic death of George Floyd, we felt it most appropriate to provide some broader perspectives on the latest consumer thinking during this chaotic time. To that end, we have looked beyond our latest analyses and that of our peers in the […]
Leadership and COVID-19: How to Lead Your Cannabis Business During a Crisis
Leading through a crisis situation like the COVID-19 pandemic is challenging in all industries, and the cannabis industry is no exception. From effectively meeting customers’ needs and generating revenue to keeping employees motivated, effective leadership is critical to keeping a cannabis business or ancillary business afloat. To be an effective leader during times of uncertainty […]
FSD Pharma Receives U.S. FDA Approval to Design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis
PRESS RELEASE TORONTO–(BUSINESS WIRE)– FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has given the company permission to submit an Investigational New Drug Application (IND) for the use of FSD-201 (ultramicronized palmitoylethanolamide, or ultramicronized PEA) to treat COVID-19, the […]
Restructuring Realities and Alternatives for Cannabis Companies in the Age of COVID-19
In the wake of COVID-19, there will be a tsunami of cannabis-related businesses looking for restructuring options. The cannabis industry has been hit especially hard in these unprecedented times. Even before COVID-19, some businesses in this industry were teetering on the brink of insolvency, given limited financing options and unforgiving capital markets. With the added […]
New York City Is Shut Down, But Its Black-Market Weed Is Booming
“There’s a morgue with refrigerated trucks down the street from me,” says one West Village customer. “If I could live in my bong right now, I’d do it” “There’s a morgue with refrigerated trucks down the street from me,” says one West Village customer. “If I could live in my bong right now, I’d do […]
Banking for marijuana companies included in Congress’ new $3 trillion coronavirus stimulus bill
The HEROES Act is likely to pass the Democratic-controlled House, but faces an uphill battle in the GOP-controlled Senate Cannabis industry advocates applauded House Democrats on Tuesday after a new $3 trillion federal stimulus bill included provisions to allow marijuana businesses access to banking. Introduced by House speaker Nancy Pelosi, the Health and Economic Recovery […]
COVID-19 & The Cannabis Industry: Ten Industry Leaders Share How Their Companies are Dealing With The Crisis
Over the last several weeks, CBE Press LLC (CBE) has been conducting research to learn from industry leadership how the COVID-19 Crisis is effecting their businesses and to learn how they are making adjustments to weather the short term storm while positioning their companies for the long-term until a vaccine is available to protect lives […]
Cannabis Industry’s “COVID-19 Disaster Recovery Playbook”
For legalized marijuana, the coronavirus (“COVID-19”) pandemic has been the worst of times and the best of times. Despite being deemed “ineligible” for much of the Coronavirus Aid, Relief and Economic Security Act (“CARES Act”) benefits, nearly derailed by commercial-contract-voiding “force majeure” provisions, and denied federal bankruptcy protection, COVID-19 has resulted in extraordinary Marijuana Related […]
